LI-RADS Treatment Response versus Modified RECIST for Diagnosing Viable Hepatocellular Carcinoma after Locoregional Therapy: A Systematic Review and Meta-Analysis of Comparative Studies.
Dennis Dong Hwan KimBo Hyun KimJoon Il ChoiSoon Nam OhSung Eun RhaPublished in: Taehan Yongsang Uihakhoe chi (2022)
The LR-TR algorithm demonstrated better specificity than mRECIST, without a significant difference in sensitivity for the diagnosis of pathologically viable HCC after LRT.